Michael Sofia
2023
In 2023, Michael Sofia earned a total compensation of $1.6M as Chief Scientific Officer at Arbutus Biopharma Corp, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $147,600 |
|---|---|
| Option Awards | $720,208 |
| Salary | $492,000 |
| Stock Awards | $238,380 |
| Other | $16,500 |
| Total | $1,614,688 |
Sofia received $720.2K in option awards, accounting for 45% of the total pay in 2023.
Sofia also received $147.6K in non-equity incentive plan, $492K in salary, $238.4K in stock awards and $16.5K in other compensation.
Rankings
In 2023, Michael Sofia's compensation ranked 725th out of 2,975 executives tracked by ExecPay. In other words, Sofia earned more than 75.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 725 out of 2,975 | 76th |
Division Manufacturing | 414 out of 1,634 | 75th |
Major group Chemicals And Allied Products | 280 out of 906 | 69th |
Industry group Drugs | 274 out of 869 | 69th |
Industry Pharmaceutical Preparations | 180 out of 627 | 71st |
Source: SEC filing on April 10, 2024.
Sofia's colleagues
We found three more compensation records of executives who worked with Michael Sofia at Arbutus Biopharma Corp in 2023.
News
Arbutus Biopharma Corp CEO William Collier's 2023 pay jumps 28% to $3.4M
April 10, 2024
Arbutus Biopharma Corp CEO William Collier's 2022 pay slips 18% to $2.6M
April 12, 2023
Arbutus Biopharma Corp CEO William Collier's 2021 pay rises 18% to $3.2M
April 11, 2022
Arbutus Biopharma Corp CEO William Collier's 2020 pay rises 17% to $2.7M
April 8, 2021
Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
April 24, 2020